Home > Healthcare > Oncology Nutrition Market > Table of Contents

Oncology Nutrition Market – By Cancer Type (Esophageal, Liver, Pancreatic, Stomach), Product Type (Protein, Vitamin, Mineral), Formulation (Standard, Elemental), Route of Administration, Dosage Type (Liquid, Powder), End-use– Global Forecast (2024 – 2032)

  • Report ID: GMI9015
  • Published Date: Apr 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 360-degree synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Rising incidence of cancer

3.2.1.2    Growing awareness of nutrition’s role in cancer care

3.2.1.3    Growing geriatric population

3.2.2    Industry pitfalls & challenges

3.2.2.1    High cost of specialized oncology nutrition products

3.2.2.2    Regulatory challenges

3.3    Growth potential analysis

3.4    Porter’s analysis

3.5    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Company positioning matrix

4.4    Strategic dashboard

Chapter 5   Market Estimates and Forecast, By Cancer Type, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Head and neck cancer

5.3    Stomach and gastrointestinal cancer

5.4    Esophageal cancer

5.5    Liver cancer

5.6    Breast cancer

5.7    Pancreatic cancer

5.8    Lung cancer

5.9    Other cancer types

Chapter 6   Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Vitamins and minerals

6.3    Proteins

6.4    Antioxidants

6.5    Other product types

Chapter 7   Market Estimates and Forecast, By Formulation, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Standard

7.3    Elemental

Chapter 8   Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    Oral

8.3    Parenteral

Chapter 9   Market Estimates and Forecast, By Dosage Type, 2021 – 2032 ($ Mn)

9.1    Key trends

9.2    Liquid

9.3    Powder

9.4    Other dosage types

Chapter 10   Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)

10.1   Key trends

10.2   Hospitals

10.3   Clinics

10.4   Homecare

10.5   Other end-users

Chapter 11   Market Estimates and Forecast, By Region, 2021– 2032 ($ Mn)

11.1   Key trends

11.2   North America

11.2.1    U.S.

11.2.2    Canada

11.3   Europe

11.3.1    Germany

11.3.2    UK

11.3.3    France

11.3.4    Spain

11.3.5    Italy

11.3.6    Rest of Europe

11.4   Asia Pacific

11.4.1    Japan

11.4.2    China

11.4.3    India

11.4.4    Australia

11.4.5    Rest of Asia Pacific

11.5   Latin America

11.5.1    Brazil

11.5.2    Mexico

11.5.3    Rest of Latin America

11.6   Middle East and Africa

11.6.1    South Africa

11.6.2    Saudi Arabia

11.6.3    Rest of Middle East and Africa

Chapter 12   Company Profiles

12.1   Abbott Laboratories

12.2   Baxter International Inc.

12.3   B. Braun Melsungen AG

12.4   Danone (Nutricia)

12.5   Fresenius SE & Co. KGaA

12.6   Grifol S.A.

12.7   Hormel Foods Corporation

12.8   Meiji Holdings Co., Ltd.

12.9   Medtrition Inc.

12.10    Nestle S.A.

12.11    Victus, Inc.

   

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 230
  • Countries covered: 19
  • Pages: 140
 Download Free Sample